Business Wire News with Multimedia: Fresenius Kabi Introduces Levofloxacin IV in Freeflex® Container

Business Wire News with Multimedia News with Multimedia distributed by Business Wire

Want new traffic sources? Download a copy of our complimentary eBook today, and read about sources that most marketers are not aware of. From our sponsors

Fresenius Kabi Introduces Levofloxacin IV in Freeflex® Container Aug 29th 2013, 19:19 LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi USA announced today the availability of Levofloxacin in 5% Dextrose Injection in freeflex® containers. Freeflex® is an innovative container designed for infusion solutions that has been marketed globally since 2005 and in the U.S. since 2008. Freeflex's multilayer polyolefin film is PVC-free, plasticizer-free, non-DEHP and designed for easy handling with enhanced safety, environmental performance in mind. "The introduction of Levofloxacin using Media files: Logo%20Use%20for%20Web,%20IT.jpg (image/jpeg, 0 MB)

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions